Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
10.1186/s12943-021-01369-9 154 LooC.-Y.SiewE
Cardiovascular safety data from published trials showed reductions in systolic blood pressure (ranging from 4.3 to 7.9 mmHg depending on dose) and diastolic blood pressure (2.3 to 4.6 mmHg reductions)
This further supports the key role of dysbiosis in the development of visceral hypersensitivity and suggests that regulating the gut microbiota may be a new strategy for treating IBS-related visceral pain
The funders of this study had no role in design and conduct of the study
US$ 29.74
US$ 25.85
US$ 28.83
US$ 24.00
US$ 21.51
US$ 26.26
US$ 22.76
US$ 24.28
